Joerg J Moehrle (Jörg J Möhrle, Joerg Mohrle, Jörg Möhrle)

ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 13

Top Venues

Antimicrobial agents and chemotherapy

Clinical and translational science

PLOS global public health

Microorganisms

Medicines for Malaria Venture

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Medicines for Malaria Venture Jul 01 2005

Switzerland

VP, Head of Translational Medicine :: R&D,

Publications

Nada Abla, Lisa M Almond, Jennifer J Bonner, Naomi Richardson, Timothy N C Wells, Joerg J Moehrle
PBPK-led assessment of antimalarial drugs as candidates for Covid-19: Simulating concentrations at the site of action to inform repurposing strategies. Clinical and translational science 17 (7) (2024)
Nada Abla, Lisa M Almond, Jennifer J Bonner, Naomi Richardson, Timothy N C Wells, Joerg J Moehrle
PBPK-led assessment of antimalarial drugs as candidates for Covid-19: Simulating concentrations at the site of action to inform repurposing strategies. Clinical and translational science 17 (7) (2024)
María-Belén Jiménez-Díaz, Joerg J Moehrle, Inigo Angulo-Barturen, Claudia Demarta-Gatsi
Using Cryopreserved Plasmodium falciparum Sporozoites in a Humanized Mouse Model to Study Early Malaria Infection Processes and Test Prophylactic Treatments. Microorganisms 11 (9) (2023)
Lydia Burgert, Theresa Reiker, Monica Golumbeanu, Joerg J Moehrle, Melissa A Penny
Model-informed target product profiles of long-acting-injectables for use as seasonal malaria prevention. PLOS global public health 2 (3) (2022)
Joerg J Moehrle
Development of New Strategies for Malaria Chemoprophylaxis: From Monoclonal Antibodies to Long-Acting Injectable Drugs. Tropical medicine and infectious disease 7 (4) (2022)
Sebastian G Wicha, Annabelle Walz, Mohammed H Cherkaoui-Rbati, Nils Bundgaard, Karsten Kuritz, Christin Gumpp, Nathalie Gobeau, Joerg J Moehrle, Matthias Rottmann, Claudia Demarta-Gatsi
New In Vitro Interaction-Parasite Reduction Ratio Assay for Early Derisk in Clinical Development of Antimalarial Combinations. Antimicrobial agents and chemotherapy 66 (11) (2022)
Georges F R Radohery, Annabelle Walz, Christin Gumpp, Mohammed H Cherkaoui-Rbati, Nathalie Gobeau, Jeremy Gower, Miles P Davenport, Matthias Rottmann, James S McCarthy, Joerg J Moehrle, Maria Rebelo, Claudia Demarta-Gatsi, David S Khoury
Parasite Viability as a Measure of In Vivo Drug Activity in Preclinical and Early Clinical Antimalarial Drug Assessment. Antimicrobial agents and chemotherapy 66 (7) (2022)
Thanaporn Wattanakul, Mark Baker, Joerg J Moehrle, Brett McWhinney, Richard M Hoglund, James S McCarthy, Joel Tarning
Semimechanistic Pharmacokinetic and Pharmacodynamic Modeling of Piperaquine in a Volunteer Infection Study with Plasmodium falciparum Blood-Stage Malaria. Antimicrobial agents and chemotherapy 65 (4) (2021)
M Farouk Chughlay, Karen I Barnes, Myriam El Gaaloul, Nada Abla, Joerg J Moehrle, Paul Griffin, Paul van Giersbergen, Stephanie E Reuter, Hayley B Schultz, Anita Kress, Peter Tapley, Rebecca A Webster, Timothy Wells, James S McCarthy, Bridget E Barber, Louise Marquart, Michelle J Boyle, Christian R Engwerda, Stephan Chalon
Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Co-administered Ruxolitinib and Artemether-Lumefantrine in Healthy Adults. Antimicrobial agents and chemotherapy (2021)
Lydia Burgert, Sophie G Zaloumis, Saber Dini, Louise Marquart, Pengxing Cao, Mohammed Cherkaoui, Nathalie Gobeau, James S McCarthy, Julie A Simpson, Joerg J Moehrle, Melissa A Penny
Parasite-Host Dynamics throughout Antimalarial Drug Development Stages Complicate the Translation of Parasite Clearance. Antimicrobial agents and chemotherapy 65 (4) (2021)
Phumla Sinxadi, Cristina Donini, Hilary Johnstone, Grant Langdon, Lubbe Wiesner, Elizabeth Allen, Stephan Duparc, Stephan Chalon, James S McCarthy, Ulrike Lorch, Kelly Chibale, Joerg J Moehrle, Karen I Barnes
Safety, Tolerability, Pharmacokinetics, and Antimalarial Activity of the Novel Plasmodium Phosphatidylinositol 4-Kinase Inhibitor MMV390048 in Healthy Volunteers. Antimicrobial agents and chemotherapy 64 (4) (2020)
Rebecca E Watts, Anand Odedra, Louise Marquart, Lachlan Webb, Azrin N Abd-Rahman, Laura Cascales, Stephan Chalon, Maria Rebelo, Zuleima Pava, Katharine A Collins, Cielo Pasay, Nanhua Chen, Christopher L Peatey, Joerg J Moehrle, James S McCarthy
Safety and parasite clearance of artemisinin-resistant Plasmodium falciparum infection: A pilot and a randomised volunteer infection study in Australia. PLoS medicine 17 (8) (2020)
Katharine A Collins, Thomas Rückle, Suzanne Elliott, Louise Marquart, Emma Ballard, Stephan Chalon, Paul Griffin, Joerg J Moehrle, James S McCarthy
DSM265 at 400 Milligrams Clears Asexual Stage Parasites but Not Mature Gametocytes from the Blood of Healthy Subjects Experimentally Infected with Plasmodium falciparum. Antimicrobial agents and chemotherapy 63 (4) (2019)

Joerg J Moehrle.css-eqlu8i{font-size:small;padding-left:4px;} (Jörg J Möhrle, Joerg Mohrle, Jörg Möhrle)

Publication Activity (10 Years)

Top Topics

Top Venues

Joerg J Moehrle (Jörg J Möhrle, Joerg Mohrle, Jörg Möhrle)